One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients
- 15 August 2003
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 92 (4) , 436-439
- https://doi.org/10.1016/s0002-9149(03)00661-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery diseaseAmerican Heart Journal, 2001
- Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF 165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial IschemiaCirculation, 2000
- Transmyocardial revascularization with CO2 laser in patients with refractory angina pectorisJournal of the American College of Cardiology, 2000
- Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Gene therapy with vascular endothelial growth factor for inoperable coronary artery diseaseThe Annals of Thoracic Surgery, 1999
- Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trialThe Lancet, 1999
- Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trialThe Lancet, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Vascular Endothelial Growth Factor-C (VEGF-C/VEGF-2) Promotes Angiogenesis in the Setting of Tissue IschemiaThe American Journal of Pathology, 1998
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997